Status:
NOT_YET_RECRUITING
Effects of Transcranial Photobiomodulation in ADHD
Lead Sponsor:
University of Texas at Austin
Conditions:
Attention Deficit Hyperactivity Disorder
Eligibility:
All Genders
18-44 years
Phase:
NA
Brief Summary
The investigators have previously shown that non-invasive methods of brain stimulation such as the administration of transcranial infrared light to the prefrontal cortex (PFC) can result in improvemen...
Detailed Description
This will be a double-blind, sham-controlled study to evaluate the neurobehavioral and PFC neurometabolic effects of repeated tPBM sessions in adults with ADHD. Adults with a history of medically-diag...
Eligibility Criteria
Inclusion
- English-speaking
- Adults of any sex
- Age range: 18-44 years
- Any ethnic/racial background
- Medical history of ADHD
- Participants may either be on a stable ADHD medication regimen (with no changes within two weeks prior to the study) or not taking medication.
Exclusion
- Currently pregnancy
- Any sham or active photobiomodulation treatment within the past five weeks.
Key Trial Info
Start Date :
November 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT07203092
Start Date
November 1 2025
End Date
December 1 2027
Last Update
October 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Texas at Austin
Austin, Texas, United States, 78701